8-K: Ensign Group Reports Record 2025 Results, Issues Strong 2026 Guidance

The Ensign Group, Inc. announced record fiscal year and fourth quarter 2025 financial results, with significant growth in earnings and revenue, and provided optimistic 2026 guidance.

Summary

• GAAP diluted earnings per share for the fiscal year 2025 was $5.84, marking a 14.1% increase over the prior year.
• Adjusted diluted earnings per share for the fiscal year 2025 reached $6.57, an increase of 19.5% compared to the prior year.
• Consolidated revenue for the fiscal year 2025 was $5.06 billion, up 18.7% from the prior year.
• For the fourth quarter of 2025, GAAP diluted earnings per share was $1.61, an 18.4% increase, and adjusted diluted earnings per share was $1.82, up 22.1% over the prior year quarter.
• The company's consolidated revenue for Q4 2025 was $1.36 billion, representing a 20.2% increase from the prior year quarter.
• Same Facilities and Transitioning Facilities occupancy for Q4 2025 reached all-time highs of 83.8% and 84.9%, respectively.
• The company issued annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion.
• The midpoint of the 2026 earnings guidance represents a 14.3% increase over 2025 results and is 36.5% higher than 2024 results.
• The company acquired 51 operations during 2025 and since, including 17 new operations (12 real estate assets) during Q4 2025 and since.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a highly positive report, driven by record financial performance, robust organic growth, successful acquisition strategy, strong liquidity, and optimistic guidance for 2026, all underpinned by demonstrated clinical excellence.

Positives

• Record GAAP diluted EPS of $5.84 for FY2025, a 14.1% increase year-over-year.
• Record Adjusted diluted EPS of $6.57 for FY2025, a 19.5% increase year-over-year.
• Consolidated revenue reached $5.06 billion for FY2025, an 18.7% increase.
• Strong Q4 2025 performance with GAAP diluted EPS up 18.4% and Adjusted diluted EPS up 22.1% year-over-year.
• Same Facilities and Transitioning Facilities occupancy for Q4 2025 reached all-time highs of 83.8% and 84.9%, respectively.
• Skilled days increased by 8.5% for Same Facilities and 10.0% for Transitioning Facilities in Q4 2025.
• Medicare revenue improved by 15.7% for Same Facilities and 11.3% for Transitioning Facilities in Q4 2025.
• Standard Bearer segment revenue increased by 33.5% for the year to $126.9 million and FFO increased by 28.3% to $75.2 million.
• Strong liquidity with $503.9 million cash on hand and $591.6 million available capacity under its line-of-credit.
• Increased quarterly cash dividend for the 23rd consecutive year to $0.065 per share.
• Outperformed peers in CMS annual survey results by 24% at the state level and 33% at the county level.
• Maintained a 19% advantage in overall 4and 5-star rated buildings compared to peers, despite many being 1and 2-star at acquisition.
• Significant acquisition activity, adding 51 operations in 2025 and since, including 17 new operations (12 real estate assets) in Q4 2025 and since.

Negatives

• Non-GAAP adjustments include litigation costs, which were $12.0 million for the year ended December 31, 2025.
• The use of non-GAAP measures may not be comparable with other companies in the industry.

Risks

• Reduced prices and reimbursement rates for services.
• Ability to acquire, develop, manage, or improve operations.
• Ability to manage increasing borrowing costs due to additional indebtedness to fund the acquisition and development of operations.
• Ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy.
• Operating margins and profitability could suffer if unable to grow and manage effectively an increasing number of operations.
• Competition from other companies in the acquisition, development, and operation of facilities.
• Ability to defend claims and lawsuits, including professional liability claims alleging that services resulted in personal injury, and other regulatory-related claims.
• Application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit business operations, require significant expenditures, or limit ability to relocate operations if necessary.
• The business and operations continue to be impacted by the unprecedented nature of changes in regulations and the environment, making it difficult to predict the full extent and duration of the financial impact on business, financial condition, and results of operations.

Future Outlook

The company issued annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion. The midpoint of this earnings guidance represents a 14.3% increase over 2025 results. The company anticipates continued organic improvements and plans to capitalize on acquisition opportunities, with several new additions expected in the first quarter of 2026.

Management Comments

• "We are excited to report another record year and record quarter in several key areas." Barry Port, Chief Executive Officer.
• "Our clinical achievements are bearing fruit in several ways. On the census front, our same store and transitioning occupancy increased to 83.8% and 84.9% during the quarter, which are both all-time highs." Barry Port, Chief Executive Officer.
• "At 83% [occupancy], we have enough organic growth potential left in our organization to sustain our consistent earnings and revenue growth, even if we stopped acquiring." Barry Port, Chief Executive Officer.
• "We are issuing our annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion. The midpoint of this 2026 earnings guidance represents an increase of 14.3% over our 2025 results and is 36.5% higher than our 2024 results." Barry Port, Chief Executive Officer.
• "During the quarter and since we accelerated our growth by adding 17 new operations, including 12 real estate assets, bringing the number of operations acquired during 2025 and since to 51." Chad Keetch, Chief Investment Officer and Executive Vice President.
• "Our liquidity remains strong with approximately $503.9 million of cash on hand and $591.6 million of available capacity under its line-of-credit." Suzanne Snapper, Executive Vice President and Chief Financial Officer.

Industry Context

StockSavvy.ai notes that Ensign Group's strong performance, particularly in occupancy and skilled mix, indicates effective management within the post-acute healthcare sector. The continued acquisition strategy, focusing on both leased and owned real estate, positions the company to consolidate market share and leverage economies of scale in a fragmented industry facing demographic tailwinds from an aging population. The emphasis on clinical excellence, as evidenced by superior CMS ratings, suggests a competitive advantage in attracting patients and securing favorable reimbursement rates.

Comparison to Industry Standards

• Ensign-affiliated facilities outperformed their peers in annual CMS survey results by an impressive 24% at the state level and 33% at the county level.
• Ensign-affiliated operations maintained a 19% advantage in overall 4and 5-star rated buildings when compared to their peers, which is particularly noteworthy given the majority of these communities were 1and 2-star facilities at the time of acquisition.
• The company's current same-store occupancy at 83% is considered to have significant organic growth potential, with some mature operations consistently achieving and maintaining occupancies in the midto high 90s, suggesting a higher operational efficiency ceiling compared to many industry participants.

Legal Proceedings

• Non-GAAP adjustments include $12.0 million in litigation costs for the year ended December 31, 2025, related to specific proceedings arising outside of the ordinary course of business.

Related Party Transactions

• Standard Bearer, the real estate segment, has 120 owned properties leased to an Ensign-affiliated operator.
• Rental revenue generated from Ensign's independent subsidiaries was $29.3 million for Q4 2025 and $107.6 million for FY 2025.
• Standard Bearer expenses include management fees and interest from intercompany agreements between Standard Bearer and the Company's independent subsidiaries.

Stakeholder Impact

• Shareholders: Positive impact due to record earnings, strong revenue growth, optimistic future guidance, and a consistent, increasing dividend payout.
• Employees: Acknowledged for their "outstanding work" and "unwavering commitment" to patient care, contributing to clinical excellence and operational success.
• Customers/Patients: Benefit from the company's focus on clinical excellence, evidenced by high CMS ratings and improved occupancy, suggesting quality care and availability.
• Creditors: Strong liquidity and consistent profitability enhance the company's creditworthiness.

Next Steps

• Continue driving organic improvements within the existing portfolio.
• Pursue acquisition opportunities, with several new additions lining up for Q1 2026.
• Management partners will continue to manage and innovate while balancing the addition of newly acquired operations.
• The company plans to continue its long history of paying dividends.

Key Dates

Recommendation

The Ensign Group has delivered exceptional financial results for Q4 and FY 2025, demonstrating robust growth across all key metrics, including record EPS and revenue. The company's strategic focus on organic growth, coupled with a successful acquisition strategy, is yielding significant returns. Strong liquidity, a consistent dividend increase for 23 consecutive years, and a highly positive 2026 guidance further reinforce its financial health and future prospects. The demonstrated clinical excellence and superior CMS ratings provide a competitive edge in the post-acute care market. These factors collectively indicate a strong investment opportunity.

Keywords

Skilled nursing, Senior living, Post-acute care, Healthcare real estate, Healthcare facilities, Earnings report, Financial results, Acquisitions, Occupancy, Medicare, Managed care, Dividend